Literature DB >> 8689154

Renal ischaemia--reperfusion injury.

S C Weight1, P R Bell, M L Nicholson.   

Abstract

Ischaemia-reperfusion injury is a complex interrelated sequence of events that classically involves the vascular endothelium and activated leucocytes. During the ischaemic phase the endothelium is primed both to produce free radicals and to secrete chemoattractants. The resultant neutrophil sequestration serves to amplify the injury, but damage is not confined to the postischaemic area and more generalized effects typically follow. The situation in the kidney is complex for, while ischaemia primes the tissue for reperfusion damage, it also causes early and irreversible tubular injury. Furthermore, it appears that relatively less importance should be attached to the involvement of neutrophils than at other sites, and relatively more to a local postischaemic imbalance in the levels of nitric oxide and endothelin. Despite a greater understanding of the pathogenesis of ischaemia-reperfusion injury, effective treatment remains elusive and research is hampered by apparent species and organ-specific differences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689154

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  48 in total

Review 1.  Renal ischemia--reperfusion injury: an inescapable event affecting kidney transplantation outcome.

Authors:  R Böhmová; O Viklický
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

2.  Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

Authors:  Danielle G Souza; Riccardo Bertini; Angelica T Vieira; Fernando Q Cunha; Steve Poole; Marcello Allegretti; Francesco Colotta; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

3.  SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery.

Authors:  Huan Ling Liang; Filip Sedlic; Zeljko Bosnjak; Vani Nilakantan
Journal:  Free Radic Biol Med       Date:  2010-08-22       Impact factor: 7.376

4.  The carboxyproxyl-derived spin trap (CP-H) is an appropriate detector-compound for oxidative stress.

Authors:  S Adam; H Loertzer; P Fornara; H J Brömme
Journal:  Urol Res       Date:  2010-02-24

5.  MicroRNA-24 antagonism prevents renal ischemia reperfusion injury.

Authors:  Johan M Lorenzen; Tamas Kaucsar; Celina Schauerte; Roland Schmitt; Song Rong; Anika Hübner; Kristian Scherf; Jan Fiedler; Filippo Martino; Regalla Kumarswamy; Malte Kölling; Inga Sörensen; Hebke Hinz; Joerg Heineke; Eva van Rooij; Hermann Haller; Thomas Thum
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

6.  Ischaemic/reperfusion injury: Role of infliximab.

Authors:  Atul Bagul
Journal:  World J Transplant       Date:  2012-06-24

Review 7.  Tissue damage and oxidant/antioxidant balance.

Authors:  Abdullah Kisaoglu; Bunyamin Borekci; O Erkan Yapca; Habib Bilen; Halis Suleyman
Journal:  Eurasian J Med       Date:  2013-02

8.  The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-12-25

9.  Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Authors:  Virginie Pétrilli; Zdenko Herceg; Paul O Hassa; Nimesh S A Patel; Rosanna Di Paola; Ulrich Cortes; Laura Dugo; Helder-Mota Filipe; Christoph Thiemermann; Michael O Hottiger; Salvatore Cuzzocrea; Zhao-Qi Wang
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Poly[ADP-ribose] polymerase-1 expression is related to cold ischemia, acute tubular necrosis, and delayed renal function in kidney transplantation.

Authors:  Francisco O'Valle; Raimundo G M Del Moral; María del Carmén Benítez; David Martín-Oliva; Mercedes Gómez-Morales; David Aguilar; José Aneiros-Fernández; Pedro Hernández-Cortés; Antonio Osuna; Francesc Moreso; Daniel Serón; Francisco J Oliver; Raimundo G Del Moral
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.